Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Comparaison des positions d'attelles de poignet dans le syndrome du canal carpien

2 novembre 2026 mis à jour par: Fatma Merih Akpınar, Istanbul University

EFFICACITÉ DE L'ATTELLE DE POIGNET DANS DIFFÉRENTES POSITIONS DU POIGNET POUR LE TRAITEMENT DU SYNDROME DU CANAL CARPIEN : UN ESSAI CONTRÔLÉ RANDOMISÉ EN SIMPLE AVEUGLE

Carpal tunnel syndrome (CTS) is the most common nerve compression syndrome. It develops as a result of the compression of the median nerve while passing through the osteofibrous structure of the carpal tunnel located at the wrist. Sensory symptoms are the most prominent feature of CTS. These symptoms are observed as pain, paresthesia, and decreased sensory sensitivity. As motor symptoms, thumb abduction and opposition are primarily affected. In advanced cases, atrophy develops in the thenar muscles. Patients may describe weakness as difficulty in writing, opening jars, buttoning, or grasping objects. The diagnosis is made by fulfilling both clinical and electrophysiological diagnostic criteria. CTS has both conservative and surgical treatment options. Conservative treatment includes splinting, physical therapy modalities, and injection options, and it is preferred in mild and moderate cases. Among non-surgical treatment options, splint use is a commonly applied intervention; however, there is no consensus regarding its effectiveness, the optimal wrist position during use, or the duration and frequency of splint application. A total of 108 hands from patients aged 18 to 55 years diagnosed with CTS will be included in this study and randomized into three groups. All groups will be given an education and exercise program. The first group will use a wrist splint fixed at 15° flexion; the second group at neutral position; and the third group at 20° extension, to be worn only at night for eight weeks. Patients will be evaluated before treatment, immediately after treatment, and two months after the end of treatment using measures of pain- numbness severity, functional status, motor and sensory examination findings, and nerve conduction studies. What makes this study unique is that it evaluates the effects of splints that stabilize the wrist at different angles together with electrophysiological findings. A review of the literature shows that while some studies have examined and compared the effects of splints fixed at different wrist angles on symptoms, functional status, and physical examination findings, there is no study that evaluates these effects along with electrophysiological findings. Therefore, this study, which will compare the effectiveness of splints at different angles, is expected to contribute to the literature. The expected outcomes of this research are that one or more types of splints used in the conservative treatment of CTS will provide improvements in symptom severity, functional status, sensory and motor physical examination findings, and electrophysiological evaluation findings at the end of treatment.

Aperçu de l'étude

Statut

Recrutement

Les conditions

Intervention / Traitement

Type d'étude

Interventionnel

Inscription (Estimé)

108

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 65 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Diagnosis of mild to moderate carpal tunnel syndrome confirmed by electrophysiological studies performed within the last year.
  • Clinical findings consistent with carpal tunnel syndrome.
  • Age between 18 and 65 years.

Exclusion Criteria:

  • <18 years or >65 years
  • Thenar atrophy
  • Surgery history for CTS
  • Steroid injection for CTS
  • Physical treatment for CTS in the last 6 months
  • Cervical radiculopathy
  • Tenosynovitis
  • Peripheral polyneuropathy
  • Another compressive neuropathy in the ipsilateral upper extremity
  • History of trauma/fracture to the hand-wrist region
  • Pregnancy
  • Metabolic disease
  • Rheumatic/autoimmune disease
  • Kidney failure

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Groupe d'Attelle de Poignet à Flexion de 15°

Participants will wear wrist splint fixed at 15° of wrist flexion during nighttime only for eight weeks.

All participants will also receive a standardized education.

All participants will also receive a standardized exercise program.

Comparateur actif: Groupe d’attelle de poignet neutre

All participants will also receive a standardized education.

All participants will also receive a standardized exercise program.

Participants will wear a wrist splint maintaining the wrist in a neutral position during nighttime only for eight weeks.

Comparateur actif: Groupe d'attelle de poignet avec extension de 20°

All participants will also receive a standardized education.

All participants will also receive a standardized exercise program.

Participants will wear a wrist splint fixed at 20° of wrist extension during nighttime only for eight weeks.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Nerve Conduction Study (NCS)
Délai: Baseline and week 12 (follow-up)

Median motor distal latency and conduction velocity and second finger recorded median sensory distal latency and conduction velocity will be measured in all individuals. In addition to routine conduction examinations, fourth finger recorded median-ulnar peak latency comparison examinations will also be made.

Baseline and week 12 (follow-up)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Visual Pain Scale (VAS)
Délai: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

Pain and numbness at rest, at night, and during movement will be assessed using a visual analog scale (VAS) ranging from 0 to 10, where 0 represents "no pain" and 10 represents "unbearable pain."

Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
Boston Carpal Tunnel Syndrome Questionnaire (BCTSQ)
Délai: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

BCTSQ assesses the severity of symptoms and functional status in patients with carpal tunnel syndrome. The symptom severity scale assesses the symptoms with respect to severity, frequency, time and type. The scale consists of 11 questions with multiple-choice responses, scored from 1 point (mildest) to 5 points (most severe). The overall symptom severity score is calculated as the mean of the scores for the eleven individual items. The functional status scale assesses the affect of the carpal tunnel syndrome on daily living. The scale consists of 8 questions with multiple choice responses, scored from 1 point (no difficulty with the activity) to 5 points (can not perform the activity at all). The overall score for functional status was calculated as the mean of all eight. Thus, a higher symptom severity or functional status score indicates worse symptoms or dysfunction.

Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
Semmes Weinstein Monofilament Test (SWMT)
Délai: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

Using 20 pieces of SWMT, sensitive touch threshold sensitivity of each hand will be tested. The examiner and the subject will seated opposite each other. Both arms of the subject will arranged on a table in supination, with palm upwards. The patient will be instructed to close their eyes. The monofilaments will be touched fingertips of first three fingers on the radial side of both hands, with enough force to bend the monofilament for 1.5 seconds. The thinnest monofilament numbers that the patient feels being touched will be recorded.

Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
Two Point Discrimination Test (TPDT)
Délai: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

Two point discrimination sense will be evaluated statically using an esthesiometer. The examiner and the subject will seated opposite each other. Both arms of the subject will arranged on a table in supination, with palm upwards. The patient will be instructed to close their eyes. The contact time of the discriminator with the fingertip ranged from 3 to 5 seconds. The evaluation will be started by touching a single point on the first three fingertips on the radial side of both hands. Each three fingers will be evaluated separately and the distance between the two touched points will be increased by 1mm in each measurement. The smallest values will be taken in millimeters which the patient feels the two points as two separate points on the tested hand will be noted and the the average value written as the result.

Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
Hand Grip Force
Délai: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

The squeeze force will be measured while the patients are sitting, with the elbow in 90 degrees flexion and they will be asked to make a maximally voluntary grip. Measurements will be made three times in a row on both hands and the average of the three measurements will be noted as a result in kilogram (kg).

Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
Thumb and Forefinger Pinch Force
Délai: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

The pinch force with thumb and forefinger will be measured while the patients are sitting, with the elbow in 90 degrees flexion and they will be asked to make a maximally voluntary grip.The pinch force will be measured as kg with a pinch dynamometer, and the average of the three measurements will be noted as a result.

Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
Manuel Muscle Testing of M. Abductor Pollicis Brevis
Délai: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

Manual muscle testing will be evaluated in 5 grades. No visible or palpable muscle contraction 0, visible or palpable muscle contraction without motion grade 1, muscle contraction that creates movement at full of range of motion when gravity is eliminated grade 2, muscle contraction that creates movement at full of range of motion against gravity grade 3, muscle contraction that creates movement at full of range of motion against gravity and moderate resistance grade 4, muscle contraction that creates movement through the entire range of motion of the joint against gravity and full resistance will be considered as the grade 5

Baseline, Week 8 (end of intervention) and Week 12 (follow-up)
Vibration Sensation
Délai: Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

Vibration sense was tested with tuning fork. The examiner and the subject will be seated opposite each other. Both arms of the subject will be arranged on a table in supination, with palm upwards. The patient will be instructed to close their eyes. Vibrating tuning fork will be placed on the palmar aspect of the distal phalanx of first three fingers on the radial side of both hands, The patient will be asked to say 'done' when the vibration in his hand was over. The average of three measurements will be noted as a result in seconds.

Baseline, Week 8 (end of intervention) and Week 12 (follow-up)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 mars 2026

Achèvement primaire (Estimé)

1 janvier 2029

Achèvement de l'étude (Estimé)

1 janvier 2029

Dates d'inscription aux études

Première soumission

3 mars 2026

Première soumission répondant aux critères de contrôle qualité

3 mars 2026

Première publication (Réel)

9 mars 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

4 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

2 novembre 2026

Dernière vérification

1 mars 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • E-29624016-050.99-3310018

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

INDÉCIS

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .